OsteoBites: José Granados Soler, DVM, MSc, PhD & Rachel Allavena, PhD

OsteoBites: José Granados Soler, DVM, MSc, PhD & Rachel Allavena, PhD

Exploring Novel Immunotherapies for Canine Osteosarcoma

By MIB Agents

Date and time

Thursday, May 30 · 12 - 1pm PDT

Location

Online

About this event

  • 1 hour

Osteosarcoma Webinar Series: José Granados Soler, DVM, MSc, PhD and Rachel Allavena, PhD from the University of Queensland School of Veterinary Science will discuss exploring novel immunotherapies for canine osteosarcoma.

During this presentation, we'll delve into a pioneering clinical trial for canine osteosarcoma, sharing cutting-edge insights and explore how our novel immunotherapies could revolutionize treatment outcomes for our furry companions. Join us to uncover breakthroughs and a path forward in fighting this aggressive cancer.

Dr. José Granados Soler, DVM, MSc, PhD, a graduate of the National University of Colombia, initially pursued small animal surgery before transitioning into roles as an educator and researcher. His academic journey led him to Spain and Germany, where he focused on feline and canine mammary cancer research during his master's and doctoral studies. Now based in Australia at the University of Queensland, Dr. Granados Soler serves as a small animal surgeon, educator, and researcher, collaborating with Prof. Allavena on pioneering immunotherapeutic trials for osteosarcoma and other cancers in dogs. He remains dedicated to making impactful contributions to the field, with a steadfast commitment to continuous learning and improvement.

Prof Rachel Allavena is the Deputy Head of the School of Veterinary Science, The University of Queensland. She teaches toxicology, pathology, animal welfare and laboratory animal science to science and veterinary students. Prof Allavena is a specialist veterinary anatomic pathologist and is board certified by the American College of Veterinary Pathologists. Her research interest focuses on translational and comparative medicine. Principally on pet dogs with natural cancer as a translational model for oncology research, on which she presented at TEDx talk. Her canine trials have focused on bone cancer, melanoma, lymphoma and mastocytoma. Her research includes biomedical device development, koala conservation, racing animal welfare and production animal disease and economics. Since commencing her academic career in 2011 she has received AUD $13.7 million of grant and contract funding for research, published over 60 peer reviewed journal articles and won several teaching awards, including UQ’s Citation for Outstanding Contribution to Student Learning in 2021.

After a short presentation on this research, he will take questions from attendees. Share your questions in advance with us at Christina@MIBAgents.org.

Organized by